Recently, a study involving patients with concomitant PSC and inflammatory bowel disease (IBD) reported a transcriptional signature associated with an increased risk of colon dysplasia that is characterized by a pathogenic IL-17 signature in T cells.35 Here, IL17A is linked to inflammatory bowel disease.